- Press Release
January 21, 2025
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE
- Press Release
January 13, 2025
CARMEL, Ind., Jan. 13, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE
- Press Release
January 8, 2025
Revenues in 4Q24 increased approximately 50% versus 4Q23 Cash balance as of 12/31/24 was approximately
- Press Release
January 6, 2025
CARMEL, Ind., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE
- Press Release
December 10, 2024
RED has been designed to duplicate test performance of traditional balloon expulsion test (BET) and
- Press Release
November 12, 2024
Conference call will be held today, Tuesday, November 12 at 9:00 am ET CARMEL, Ind.,
- Press Release
November 5, 2024
CARMEL, Ind., Nov. 05, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE
- Press Release
November 4, 2024
Clearance expands indication for use from 11-18 year olds to 8-21 year olds; and from
- Press Release
October 29, 2024
CARMEL, Ind., Oct. 29, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE
- Press Release
October 22, 2024
CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE